381 related articles for article (PubMed ID: 33182043)
1. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice.
Feng Z; Pang L; Chen S; Pang X; Huang Y; Qiao Q; Wang Y; Vonglorkham S; Huang Q; Lin X; Wei J
Int Immunopharmacol; 2020 Nov; 88():107003. PubMed ID: 33182043
[TBL] [Abstract][Full Text] [Related]
2. Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice.
Wu J; Chen P; Ju L; Gao R; Li S; Huang Z; Cheng Y; Gui S; Qiu Z; Cheng J; Huang F
Biomed Pharmacother; 2022 Jul; 151():113132. PubMed ID: 35623174
[TBL] [Abstract][Full Text] [Related]
3. Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury.
Pang L; Xiong Y; Feng Z; Li C; Fang B; Huang Q; Lin X
Mediators Inflamm; 2023; 2023():6051946. PubMed ID: 36687218
[TBL] [Abstract][Full Text] [Related]
4. Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein.
Lin X; Bai F; Nie J; Lu S; Lu C; Zhu X; Wei J; Lu Z; Huang Q
Cell Physiol Biochem; 2016; 40(6):1422-1432. PubMed ID: 27997902
[TBL] [Abstract][Full Text] [Related]
5. MiR-217 inhibits apoptosis of atherosclerotic endothelial cells via the TLR4/PI3K/Akt/NF-κB pathway.
Zhang B; Zhang YF; Li R; Zhao L; Qin SG; Pan LF; Gao YX
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12867-12877. PubMed ID: 33378037
[TBL] [Abstract][Full Text] [Related]
6. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
Wang L; Jia Z; Wang B; Zhang B
Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
[TBL] [Abstract][Full Text] [Related]
7. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
9. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J
Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882
[TBL] [Abstract][Full Text] [Related]
10. Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
Vasudevan Sajini D; Thaggikuppe Krishnamurthy P; Chakkittukandiyil A; Mudavath RN
Neurochem Res; 2024 Jun; 49(6):1577-1587. PubMed ID: 38276990
[TBL] [Abstract][Full Text] [Related]
11. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.
Pisonero-Vaquero S; Martínez-Ferreras Á; García-Mediavilla MV; Martínez-Flórez S; Fernández A; Benet M; Olcoz JL; Jover R; González-Gallego J; Sánchez-Campos S
Mol Nutr Food Res; 2015 May; 59(5):879-93. PubMed ID: 25712622
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats.
Xu X; Wang W; Lin L; Chen P
Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722
[TBL] [Abstract][Full Text] [Related]
13. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
14. Coactivation of the PI3K/Akt and ERK signaling pathways in PCB153-induced NF-κB activation and caspase inhibition.
Liu C; Yang J; Fu W; Qi S; Wang C; Quan C; Yang K
Toxicol Appl Pharmacol; 2014 Jun; 277(3):270-8. PubMed ID: 24726520
[TBL] [Abstract][Full Text] [Related]
15. Telluric acid ameliorates hepatic ischemia reperfusion-induced injury in rats: Involvement of TLR4, Nrf2, and PI3K/Akt signaling pathways.
Rabie MA; Zaki HF; Sayed HM
Biochem Pharmacol; 2019 Oct; 168():404-411. PubMed ID: 31386827
[TBL] [Abstract][Full Text] [Related]
16. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.
Li D; Guo YY; Cen XF; Qiu HL; Chen S; Zeng XF; Zeng Q; Xu M; Tang QZ
Acta Pharmacol Sin; 2022 Aug; 43(8):1989-2002. PubMed ID: 34916609
[TBL] [Abstract][Full Text] [Related]
17. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
[TBL] [Abstract][Full Text] [Related]
18. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.
Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X
J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
Xiao J; Ho CT; Liong EC; Nanji AA; Leung TM; Lau TY; Fung ML; Tipoe GL
Eur J Nutr; 2014 Feb; 53(1):187-99. PubMed ID: 23515587
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]